UniProt ID | HGS_HUMAN | |
---|---|---|
UniProt AC | O14964 | |
Protein Name | Hepatocyte growth factor-regulated tyrosine kinase substrate | |
Gene Name | HGS | |
Organism | Homo sapiens (Human). | |
Sequence Length | 777 | |
Subcellular Localization |
Cytoplasm . Early endosome membrane Peripheral membrane protein Cytoplasmic side . Endosome, multivesicular body membrane Peripheral membrane protein . Colocalizes with UBQLN1 in ubiquitin-rich cytoplasmic aggregates that are not endocytic comp |
|
Protein Description | Involved in intracellular signal transduction mediated by cytokines and growth factors. When associated with STAM, it suppresses DNA signaling upon stimulation by IL-2 and GM-CSF. Could be a direct effector of PI3-kinase in vesicular pathway via early endosomes and may regulate trafficking to early and late endosomes by recruiting clathrin. May concentrate ubiquitinated receptors within clathrin-coated regions. Involved in down-regulation of receptor tyrosine kinase via multivesicular body (MVBs) when complexed with STAM (ESCRT-0 complex). The ESCRT-0 complex binds ubiquitin and acts as sorting machinery that recognizes ubiquitinated receptors and transfers them to further sequential lysosomal sorting/trafficking processes. May contribute to the efficient recruitment of SMADs to the activin receptor complex. Involved in receptor recycling via its association with the CART complex, a multiprotein complex required for efficient transferrin receptor recycling but not for EGFR degradation.. | |
Protein Sequence | MGRGSGTFERLLDKATSQLLLETDWESILQICDLIRQGDTQAKYAVNSIKKKVNDKNPHVALYALEVMESVVKNCGQTVHDEVANKQTMEELKDLLKRQVEVNVRNKILYLIQAWAHAFRNEPKYKVVQDTYQIMKVEGHVFPEFKESDAMFAAERAPDWVDAEECHRCRVQFGVMTRKHHCRACGQIFCGKCSSKYSTIPKFGIEKEVRVCEPCYEQLNRKAEGKATSTTELPPEYLTSPLSQQSQLPPKRDETALQEEEELQLALALSQSEAEEKERLRQKSTYTSYPKAEPMPSASSAPPASSLYSSPVNSSAPLAEDIDPELARYLNRNYWEKKQEEARKSPTPSAPVPLTEPAAQPGEGHAAPTNVVENPLPETDSQPIPPSGGPFSEPQFHNGESEESHEQFLKALQNAVTTFVNRMKSNHMRGRSITNDSAVLSLFQSINGMHPQLLELLNQLDERRLYYEGLQDKLAQIRDARGALSALREEHREKLRRAAEEAERQRQIQLAQKLEIMRQKKQEYLEVQRQLAIQRLQEQEKERQMRLEQQKQTVQMRAQMPAFPLPYAQLQAMPAAGGVLYQPSGPASFPSTFSPAGSVEGSPMHGVYMSQPAPAAGPYPSMPSTAADPSMVSAYMYPAGATGAQAAPQAQAGPTASPAYSSYQPTPTAGYQNVASQAPQSLPAISQPPQSSTMGYMGSQSVSMGYQPYNMQNLMTTLPSQDASLPPQQPYIAGQQPMYQQMAPSGGPPQQQPPVAQQPQAQGPPAQGSEAQLISFD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
17 | Phosphorylation | RLLDKATSQLLLETD HHHHHHHHHHHHHCC | 24.56 | 22210691 | |
27 | Phosphorylation | LLETDWESILQICDL HHHCCHHHHHHHHHH | 25.09 | 22210691 | |
40 | Phosphorylation | DLIRQGDTQAKYAVN HHHHCCCHHHHHHHH | 36.93 | 22210691 | |
43 | Ubiquitination | RQGDTQAKYAVNSIK HCCCHHHHHHHHHHH | 24.75 | - | |
50 | Acetylation | KYAVNSIKKKVNDKN HHHHHHHHHHHCCCC | 46.49 | 25953088 | |
56 | Ubiquitination | IKKKVNDKNPHVALY HHHHHCCCCHHHHHH | 68.15 | 21906983 | |
56 (in isoform 1) | Ubiquitination | - | 68.15 | 21890473 | |
56 (in isoform 2) | Ubiquitination | - | 68.15 | 21890473 | |
78 | Phosphorylation | VVKNCGQTVHDEVAN HHHHCCCHHHHHHHC | 12.70 | 20068231 | |
86 | Ubiquitination | VHDEVANKQTMEELK HHHHHHCHHHHHHHH | 37.09 | 21890473 | |
86 (in isoform 1) | Ubiquitination | - | 37.09 | 21890473 | |
86 (in isoform 2) | Ubiquitination | - | 37.09 | 21890473 | |
93 | Ubiquitination | KQTMEELKDLLKRQV HHHHHHHHHHHHHHC | 50.00 | 21890473 | |
93 (in isoform 1) | Ubiquitination | - | 50.00 | 21890473 | |
93 (in isoform 2) | Ubiquitination | - | 50.00 | 21890473 | |
97 | Ubiquitination | EELKDLLKRQVEVNV HHHHHHHHHHCHHHH | 48.35 | 20972266 | |
125 | Phosphorylation | AFRNEPKYKVVQDTY HHHCCCCCCEEECHH | 21.52 | 22817900 | |
126 | Ubiquitination | FRNEPKYKVVQDTYQ HHCCCCCCEEECHHH | 41.89 | 21890473 | |
126 (in isoform 1) | Ubiquitination | - | 41.89 | 21890473 | |
126 (in isoform 2) | Ubiquitination | - | 41.89 | 21890473 | |
131 | Phosphorylation | KYKVVQDTYQIMKVE CCCEEECHHHHHEEC | 10.55 | 28152594 | |
132 | Phosphorylation | YKVVQDTYQIMKVEG CCEEECHHHHHEECC | 12.34 | 25159151 | |
136 | Ubiquitination | QDTYQIMKVEGHVFP ECHHHHHEECCCCCC | 38.47 | 21890473 | |
136 (in isoform 1) | Ubiquitination | - | 38.47 | 21890473 | |
136 (in isoform 2) | Ubiquitination | - | 38.47 | 21890473 | |
146 | Ubiquitination | GHVFPEFKESDAMFA CCCCCCCCHHHHCHH | 55.43 | 21906983 | |
146 (in isoform 1) | Ubiquitination | - | 55.43 | 21890473 | |
146 (in isoform 2) | Ubiquitination | - | 55.43 | 21890473 | |
151 | Sulfoxidation | EFKESDAMFAAERAP CCCHHHHCHHHHCCC | 2.56 | 21406390 | |
176 | Sulfoxidation | CRVQFGVMTRKHHCR CCEECCCCCCCCCCC | 2.84 | 21406390 | |
177 | Phosphorylation | RVQFGVMTRKHHCRA CEECCCCCCCCCCCC | 33.87 | 28857561 | |
192 | Acetylation | CGQIFCGKCSSKYST CCCEEECCCCCCCCC | 31.93 | 25953088 | |
192 | Ubiquitination | CGQIFCGKCSSKYST CCCEEECCCCCCCCC | 31.93 | 21906983 | |
192 (in isoform 1) | Ubiquitination | - | 31.93 | 21890473 | |
192 (in isoform 2) | Ubiquitination | - | 31.93 | 21890473 | |
196 | Ubiquitination | FCGKCSSKYSTIPKF EECCCCCCCCCCCCC | 27.25 | 21906983 | |
196 (in isoform 1) | Ubiquitination | - | 27.25 | 21890473 | |
196 (in isoform 2) | Ubiquitination | - | 27.25 | 21890473 | |
197 | Phosphorylation | CGKCSSKYSTIPKFG ECCCCCCCCCCCCCC | 17.00 | 20068231 | |
198 | Phosphorylation | GKCSSKYSTIPKFGI CCCCCCCCCCCCCCC | 24.48 | 20068231 | |
199 | Phosphorylation | KCSSKYSTIPKFGIE CCCCCCCCCCCCCCC | 37.90 | 20068231 | |
202 | Ubiquitination | SKYSTIPKFGIEKEV CCCCCCCCCCCCCEE | 52.99 | 21890473 | |
202 (in isoform 1) | Ubiquitination | - | 52.99 | 21890473 | |
202 (in isoform 2) | Ubiquitination | - | 52.99 | 21890473 | |
207 | Acetylation | IPKFGIEKEVRVCEP CCCCCCCCEEEECHH | 60.64 | 19608861 | |
207 | Malonylation | IPKFGIEKEVRVCEP CCCCCCCCEEEECHH | 60.64 | 26320211 | |
207 | Ubiquitination | IPKFGIEKEVRVCEP CCCCCCCCEEEECHH | 60.64 | 21890473 | |
207 (in isoform 1) | Ubiquitination | - | 60.64 | 21890473 | |
207 (in isoform 2) | Ubiquitination | - | 60.64 | 21890473 | |
216 | Phosphorylation | VRVCEPCYEQLNRKA EEECHHHHHHHHHHH | 19.88 | 27273156 | |
222 | Ubiquitination | CYEQLNRKAEGKATS HHHHHHHHHCCCCCC | 50.11 | 21906983 | |
222 (in isoform 1) | Ubiquitination | - | 50.11 | 21890473 | |
222 (in isoform 2) | Ubiquitination | - | 50.11 | 21890473 | |
226 | Ubiquitination | LNRKAEGKATSTTEL HHHHHCCCCCCCCCC | 39.74 | 2266 | |
226 (in isoform 1) | Ubiquitination | - | 39.74 | 21890473 | |
226 (in isoform 2) | Ubiquitination | - | 39.74 | 21890473 | |
228 | Phosphorylation | RKAEGKATSTTELPP HHHCCCCCCCCCCCH | 30.05 | 26074081 | |
229 | Phosphorylation | KAEGKATSTTELPPE HHCCCCCCCCCCCHH | 37.89 | 26074081 | |
230 | Phosphorylation | AEGKATSTTELPPEY HCCCCCCCCCCCHHH | 21.67 | 26074081 | |
231 | Phosphorylation | EGKATSTTELPPEYL CCCCCCCCCCCHHHH | 34.98 | 26074081 | |
237 | Phosphorylation | TTELPPEYLTSPLSQ CCCCCHHHHCCCHHH | 22.51 | 27259358 | |
239 | Phosphorylation | ELPPEYLTSPLSQQS CCCHHHHCCCHHHCC | 27.65 | 22199227 | |
240 | Phosphorylation | LPPEYLTSPLSQQSQ CCHHHHCCCHHHCCC | 22.65 | 25159151 | |
243 | Phosphorylation | EYLTSPLSQQSQLPP HHHCCCHHHCCCCCC | 29.56 | 22199227 | |
246 | Phosphorylation | TSPLSQQSQLPPKRD CCCHHHCCCCCCCCC | 26.50 | 26074081 | |
251 | Ubiquitination | QQSQLPPKRDETALQ HCCCCCCCCCCCHHH | 71.22 | 21890473 | |
251 (in isoform 1) | Ubiquitination | - | 71.22 | 21890473 | |
251 (in isoform 2) | Ubiquitination | - | 71.22 | 21890473 | |
277 | Ubiquitination | SQSEAEEKERLRQKS CCHHHHHHHHHHHHH | 39.37 | 21906983 | |
277 (in isoform 1) | Ubiquitination | - | 39.37 | 21890473 | |
277 (in isoform 2) | Ubiquitination | - | 39.37 | 21890473 | |
283 | Ubiquitination | EKERLRQKSTYTSYP HHHHHHHHHCCCCCC | 38.03 | - | |
284 | Phosphorylation | KERLRQKSTYTSYPK HHHHHHHHCCCCCCC | 20.50 | 28796482 | |
285 | Phosphorylation | ERLRQKSTYTSYPKA HHHHHHHCCCCCCCC | 37.54 | 28796482 | |
286 | Phosphorylation | RLRQKSTYTSYPKAE HHHHHHCCCCCCCCC | 10.77 | 27273156 | |
287 | Phosphorylation | LRQKSTYTSYPKAEP HHHHHCCCCCCCCCC | 23.13 | 28796482 | |
288 | Phosphorylation | RQKSTYTSYPKAEPM HHHHCCCCCCCCCCC | 29.08 | 25884760 | |
289 | Phosphorylation | QKSTYTSYPKAEPMP HHHCCCCCCCCCCCC | 10.84 | 25159151 | |
291 | Ubiquitination | STYTSYPKAEPMPSA HCCCCCCCCCCCCCC | 58.09 | 21906983 | |
291 (in isoform 1) | Ubiquitination | - | 58.09 | 21890473 | |
291 (in isoform 2) | Ubiquitination | - | 58.09 | 21890473 | |
295 | Sulfoxidation | SYPKAEPMPSASSAP CCCCCCCCCCCCCCC | 2.85 | 30846556 | |
297 | O-linked_Glycosylation | PKAEPMPSASSAPPA CCCCCCCCCCCCCCC | 34.23 | 28510447 | |
297 | Phosphorylation | PKAEPMPSASSAPPA CCCCCCCCCCCCCCC | 34.23 | 21945579 | |
299 | O-linked_Glycosylation | AEPMPSASSAPPASS CCCCCCCCCCCCCHH | 31.22 | 28510447 | |
299 | Phosphorylation | AEPMPSASSAPPASS CCCCCCCCCCCCCHH | 31.22 | 21945579 | |
300 | O-linked_Glycosylation | EPMPSASSAPPASSL CCCCCCCCCCCCHHH | 44.50 | 28510447 | |
300 | Phosphorylation | EPMPSASSAPPASSL CCCCCCCCCCCCHHH | 44.50 | 21945579 | |
305 | Phosphorylation | ASSAPPASSLYSSPV CCCCCCCHHHCCCCC | 27.01 | 21945579 | |
306 | Phosphorylation | SSAPPASSLYSSPVN CCCCCCHHHCCCCCC | 33.17 | 21945579 | |
308 | Phosphorylation | APPASSLYSSPVNSS CCCCHHHCCCCCCCC | 14.73 | 21945579 | |
309 | Phosphorylation | PPASSLYSSPVNSSA CCCHHHCCCCCCCCC | 33.20 | 21945579 | |
310 | O-linked_Glycosylation | PASSLYSSPVNSSAP CCHHHCCCCCCCCCC | 21.22 | 28510447 | |
310 | Phosphorylation | PASSLYSSPVNSSAP CCHHHCCCCCCCCCC | 21.22 | 21945579 | |
314 | Phosphorylation | LYSSPVNSSAPLAED HCCCCCCCCCCCHHC | 28.28 | 21945579 | |
315 | O-linked_Glycosylation | YSSPVNSSAPLAEDI CCCCCCCCCCCHHCC | 28.80 | 28510447 | |
315 | Phosphorylation | YSSPVNSSAPLAEDI CCCCCCCCCCCHHCC | 28.80 | 21945579 | |
329 | Phosphorylation | IDPELARYLNRNYWE CCHHHHHHHHHHHHH | 11.61 | 27273156 | |
334 | Phosphorylation | ARYLNRNYWEKKQEE HHHHHHHHHHHHHHH | 16.23 | 27273156 | |
337 | Ubiquitination | LNRNYWEKKQEEARK HHHHHHHHHHHHHHC | 45.68 | 21906983 | |
337 (in isoform 1) | Ubiquitination | - | 45.68 | 21890473 | |
337 (in isoform 2) | Ubiquitination | - | 45.68 | 21890473 | |
345 | Phosphorylation | KQEEARKSPTPSAPV HHHHHHCCCCCCCCC | 28.58 | 26657352 | |
347 | Phosphorylation | EEARKSPTPSAPVPL HHHHCCCCCCCCCCC | 36.65 | 26657352 | |
349 | Phosphorylation | ARKSPTPSAPVPLTE HHCCCCCCCCCCCCC | 47.91 | 26074081 | |
355 | Phosphorylation | PSAPVPLTEPAAQPG CCCCCCCCCCCCCCC | 33.58 | 26074081 | |
369 | Phosphorylation | GEGHAAPTNVVENPL CCCCCCCCCCCCCCC | 35.60 | 26074081 | |
379 | Phosphorylation | VENPLPETDSQPIPP CCCCCCCCCCCCCCC | 38.72 | 26074081 | |
387 | Phosphorylation | DSQPIPPSGGPFSEP CCCCCCCCCCCCCCC | 51.53 | 22468782 | |
466 | Phosphorylation | QLDERRLYYEGLQDK HHHHHHHHHHHHHHH | 9.54 | 27642862 | |
467 | Phosphorylation | LDERRLYYEGLQDKL HHHHHHHHHHHHHHH | 14.23 | 25147952 | |
473 | 2-Hydroxyisobutyrylation | YYEGLQDKLAQIRDA HHHHHHHHHHHHHHH | 32.53 | - | |
473 | Ubiquitination | YYEGLQDKLAQIRDA HHHHHHHHHHHHHHH | 32.53 | 21890473 | |
473 (in isoform 1) | Ubiquitination | - | 32.53 | 21890473 | |
473 (in isoform 2) | Ubiquitination | - | 32.53 | 21890473 | |
485 | Phosphorylation | RDARGALSALREEHR HHHHHHHHHHHHHHH | 25.40 | 20860994 | |
494 | Acetylation | LREEHREKLRRAAEE HHHHHHHHHHHHHHH | 47.45 | 71051 | |
513 | Ubiquitination | RQIQLAQKLEIMRQK HHHHHHHHHHHHHHH | 42.34 | 21890473 | |
513 (in isoform 1) | Ubiquitination | - | 42.34 | 21890473 | |
520 | Ubiquitination | KLEIMRQKKQEYLEV HHHHHHHHHHHHHHH | 46.16 | - | |
521 | Ubiquitination | LEIMRQKKQEYLEVQ HHHHHHHHHHHHHHH | 39.77 | 21906983 | |
521 (in isoform 1) | Ubiquitination | - | 39.77 | 21890473 | |
524 | Phosphorylation | MRQKKQEYLEVQRQL HHHHHHHHHHHHHHH | 12.98 | 28796482 | |
541 | Ubiquitination | QRLQEQEKERQMRLE HHHHHHHHHHHHHHH | 58.87 | 21906983 | |
541 (in isoform 1) | Ubiquitination | - | 58.87 | 21890473 | |
551 | Succinylation | QMRLEQQKQTVQMRA HHHHHHHHHHHHHHH | 47.86 | - | |
551 | Succinylation | QMRLEQQKQTVQMRA HHHHHHHHHHHHHHH | 47.86 | 2190698 | |
551 | Ubiquitination | QMRLEQQKQTVQMRA HHHHHHHHHHHHHHH | 47.86 | - | |
551 (in isoform 1) | Ubiquitination | - | 47.86 | 21890473 | |
553 | Phosphorylation | RLEQQKQTVQMRAQM HHHHHHHHHHHHHHC | 21.53 | 29083192 | |
567 | Phosphorylation | MPAFPLPYAQLQAMP CCCCCCCHHHHHCCC | 18.05 | 20068231 | |
581 | Phosphorylation | PAAGGVLYQPSGPAS CCCCCEEECCCCCCC | 18.90 | 20068231 | |
584 | Phosphorylation | GGVLYQPSGPASFPS CCEEECCCCCCCCCC | 41.71 | 20068231 | |
588 | Phosphorylation | YQPSGPASFPSTFSP ECCCCCCCCCCCCCC | 40.60 | 20068231 | |
591 | Phosphorylation | SGPASFPSTFSPAGS CCCCCCCCCCCCCCC | 39.82 | 20068231 | |
592 | Phosphorylation | GPASFPSTFSPAGSV CCCCCCCCCCCCCCC | 28.50 | 20068231 | |
594 | Phosphorylation | ASFPSTFSPAGSVEG CCCCCCCCCCCCCCC | 17.58 | 20068231 | |
598 | Phosphorylation | STFSPAGSVEGSPMH CCCCCCCCCCCCCCC | 21.07 | 20068231 | |
602 | Phosphorylation | PAGSVEGSPMHGVYM CCCCCCCCCCCCEEE | 12.92 | 20068231 | |
608 | Phosphorylation | GSPMHGVYMSQPAPA CCCCCCEEECCCCCC | 8.81 | 20068231 | |
610 | Phosphorylation | PMHGVYMSQPAPAAG CCCCEEECCCCCCCC | 18.48 | 20068231 | |
619 | Phosphorylation | PAPAAGPYPSMPSTA CCCCCCCCCCCCCCC | 13.66 | 20068231 | |
621 | Phosphorylation | PAAGPYPSMPSTAAD CCCCCCCCCCCCCCC | 37.17 | 20068231 | |
624 | Phosphorylation | GPYPSMPSTAADPSM CCCCCCCCCCCCHHH | 23.26 | 20068231 | |
625 | Phosphorylation | PYPSMPSTAADPSMV CCCCCCCCCCCHHHH | 21.72 | 20068231 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
329 | Y | Phosphorylation | Kinase | EGFR | P00533 | PhosphoELM |
- | K | Ubiquitination | E3 ubiquitin ligase | NEDD4 | P46934 | PMID:12230472 |
- | K | Ubiquitination | E3 ubiquitin ligase | CBL | P22681 | PMID:20029031 |
- | K | Ubiquitination | E3 ubiquitin ligase | SH3RF1 | Q7Z6J0 | PMID:16084064 |
- | K | Ubiquitination | E3 ubiquitin ligase | ITCH | Q96J02 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | NEDD4L | Q96PU5 | PMID:20675381 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HGS_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HGS_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-207, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-286; TYR-289 ANDTYR-308, AND MASS SPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-132 AND TYR-216, ANDMASS SPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-216, AND MASSSPECTROMETRY. | |
"Phosphoproteome analysis of HeLa cells using stable isotope labelingwith amino acids in cell culture (SILAC)."; Amanchy R., Kalume D.E., Iwahori A., Zhong J., Pandey A.; J. Proteome Res. 4:1661-1671(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-308, AND MASSSPECTROMETRY. |